MetaADEDB 2.0 @ LMMD
Cysteamine
(UFULAYFCSOUIOV-UHFFFAOYSA-N)
Structure
SMILES
NCCS
Type(s)
Approved; Investigational
ATC code(s)
A16AA04; S01XA21
Molecular Formula:
C2H7NS
Molecular Weight:
77.149
Log P:
0.5752
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
64.82
CAS Number(s):
60-23-1
Synonym(s)
1.
Cysteamine
2.
Cysteinamine
3.
Mercaptamine
4.
2-Aminoethanethiol
5.
Becaptan
6.
Cystagon
7.
Cysteamine Bitartrate
8.
Cysteamine Dihydrochloride
9.
Cysteamine Hydrobromide
10.
Cysteamine Hydrochloride
11.
Cysteamine Maleate (1:1)
12.
Cysteamine Tartrate
13.
Cysteamine Tartrate (1:1)
14.
Cysteamine Tosylate
15.
Cysteamine, 35S-Labeled
16.
Mercamine
17.
Mercaptoethylamine
18.
beta-Mercaptoethylamine
19.
2 Aminoethanethiol
20.
35S-Labeled Cysteamine
21.
Bitartrate, Cysteamine
22.
Cysteamine, 35S Labeled
23.
Dihydrochloride, Cysteamine
24.
Hydrobromide, Cysteamine
25.
Hydrochloride, Cysteamine
26.
Tartrate, Cysteamine
27.
Tosylate, Cysteamine
28.
beta Mercaptoethylamine
External Link(s)
MeSHD003543
PubChem Compound6058
118985556
BindingDB7968
ChEBI17141
CHEMBLCHEMBL602
DrugBankDB00847
DrugCentral768
IUPHAR/BPS Guide to PHARMACOLOGY7440
KEGGcpd:C01678
dr:D03634
Therapeutic Target DatabaseD0V0LB
ZINC8034121
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 18US FAERS
2VomitingFAERS: 10SIDER
US FAERS
3Eye painFAERS: 8SIDER
US FAERS
4PhotophobiaFAERS: 6US FAERS
5NauseaFAERS: 5SIDER
US FAERS
6Portal HypertensionFAERS: 5US FAERS
7PneumoniaFAERS: 4US FAERS
8Skin lesionFAERS: 4US FAERS
9Burning sensationFAERS: 3US FAERS
10FatigueFAERS: 3SIDER
US FAERS
11HeadacheFAERS: 3SIDER
US FAERS
12SplenomegalyFAERS: 3US FAERS
13Abdominal discomfortFAERS: 2US FAERS
14AscitesFAERS: 2US FAERS
15Biopsy stomach abnormalFAERS: 2US FAERS
16Blood creatinine increasedFAERS: 2US FAERS
17Cerebrovascular accidentFAERS: 2US FAERS
18Chest PainFAERS: 2US FAERS
19ChillsFAERS: 2US FAERS
20Compression fractureFAERS: 2SIDER
US FAERS
21ConjunctivitisFAERS: 2US FAERS
22DehydrationFAERS: 2SIDER
US FAERS
23Drug ineffectiveFAERS: 2US FAERS
24DysplasiaFAERS: 2US FAERS
25Electrolyte imbalanceFAERS: 2US FAERS
26Erosive DuodenitisFAERS: 2US FAERS
27HepatomegalyFAERS: 2US FAERS
28InfectionFAERS: 2US FAERS
29Nodular regenerative hyperplasiaFAERS: 2US FAERS
30OsteopeniaFAERS: 2SIDER
US FAERS
31PainFAERS: 216563475CTD
US FAERS
32Portal Vein ThrombosisFAERS: 2US FAERS
33SepsisFAERS: 2US FAERS
34Umbilical herniaFAERS: 2US FAERS
35Visual ImpairmentFAERS: 2US FAERS
36Wrong doseFAERS: 2US FAERS
37Abdominal PainFAERS: 1SIDER
US FAERS
38Accidental overdoseFAERS: 1US FAERS
39Acute Coronary SyndromeFAERS: 1US FAERS
40Adverse eventFAERS: 1US FAERS
41AmnesiaFAERS: 1US FAERS
42AngerFAERS: 1US FAERS
43Antiphospholipid SyndromeFAERS: 1US FAERS
44AnuriaFAERS: 1US FAERS
45AnxietyFAERS: 1US FAERS
46ApathyFAERS: 1US FAERS
47AsterixisFAERS: 1US FAERS
48AstheniaFAERS: 1SIDER
US FAERS
49AtelectasisFAERS: 1US FAERS
50Back PainFAERS: 1US FAERS
51Blood electrolytes decreasedFAERS: 1US FAERS
52Blood homocysteine abnormalFAERS: 1US FAERS
53Blood urea increasedFAERS: 1US FAERS
54Complement factor C3 decreasedFAERS: 1US FAERS
55Creatinine renal clearance decreasedFAERS: 1US FAERS
56Cystic FibrosisFAERS: 1US FAERS
57CystinosisFAERS: 122532830
23651769
CTD
US FAERS
58DementiaFAERS: 1US FAERS
59Diabetes MellitusFAERS: 1US FAERS
60DiplopiaFAERS: 1US FAERS
61Disease ProgressionFAERS: 1US FAERS
62Disease complicationFAERS: 1US FAERS
63DizzinessFAERS: 1SIDER
US FAERS
64Drug abuserFAERS: 1US FAERS
65Drug exposure during pregnancyFAERS: 1US FAERS
66Dry skinFAERS: 1US FAERS
67Echocardiogram abnormalFAERS: 1US FAERS
68Educational problemFAERS: 1US FAERS
69Emotional disorderFAERS: 1US FAERS
70EnuresisFAERS: 1US FAERS
71EpistaxisFAERS: 1US FAERS
72Extra dose administeredFAERS: 1US FAERS
73Eye inflammationFAERS: 1US FAERS
74Eyelid margin crustingFAERS: 1US FAERS
75GastritisFAERS: 1US FAERS
76Gastrointestinal infectionFAERS: 1US FAERS
77Gastrointestinal motility disorderFAERS: 1US FAERS
78General physical health deteriorationFAERS: 1US FAERS
79HemiplegiaFAERS: 1US FAERS
80Hepatic EncephalopathyFAERS: 1US FAERS
81Hepatopulmonary SyndromeFAERS: 1US FAERS
82HordeolumFAERS: 1US FAERS
83HypersensitivityFAERS: 1SIDER
US FAERS
84HypersplenismFAERS: 1US FAERS
85HyporeflexiaFAERS: 1US FAERS
86HypothyroidismFAERS: 1US FAERS
87Impaired gastric emptyingFAERS: 1US FAERS
88ImpetigoFAERS: 1US FAERS
89Incorrect dose administeredFAERS: 1US FAERS
90Incorrect route of drug administrationFAERS: 1US FAERS
91InfluenzaFAERS: 1US FAERS
92Intelligence test abnormalFAERS: 1US FAERS
93Irritable Bowel SyndromeFAERS: 1US FAERS
94Joint stiffnessFAERS: 1US FAERS
95LethargyFAERS: 1SIDER
US FAERS
96Lupus NephritisFAERS: 1US FAERS
97Lupus-like syndromeFAERS: 1US FAERS
98MalaiseFAERS: 1US FAERS
99MalnutritionFAERS: 1SIDER
US FAERS
100Memory impairmentFAERS: 1US FAERS
101Mental RetardationFAERS: 1US FAERS
102Mental impairmentFAERS: 1US FAERS
103Mesangioproliferative glomerulonephritisFAERS: 1US FAERS
104Neonatal disorderFAERS: 1US FAERS
105Nephrotic SyndromeFAERS: 1SIDER
US FAERS
106NervousnessFAERS: 1SIDER
US FAERS
107No adverse eventFAERS: 1US FAERS
108OsteosclerosisFAERS: 1US FAERS
109OverdoseFAERS: 1US FAERS
110PO2 decreasedFAERS: 1US FAERS
111PallorFAERS: 1US FAERS
112PancytopeniaFAERS: 1US FAERS
113ParesisFAERS: 1US FAERS
114PetechiaeFAERS: 1US FAERS
115Physical examination abnormalFAERS: 1US FAERS
116PolyhydramniosFAERS: 1US FAERS
117Respiratory FailureFAERS: 1US FAERS
118Restrictive pulmonary diseaseFAERS: 1US FAERS
119Skin PapillomaFAERS: 1US FAERS
120SomnolenceFAERS: 1SIDER
US FAERS
121StaringFAERS: 1US FAERS
122Tracheal StenosisFAERS: 1US FAERS
123Tracheostomy malfunctionFAERS: 1US FAERS
124Acquired Immunodeficiency Syndrome9207937CTD
125AgitationSIDER
126Anaphylactic shockSIDER
127AnorexiaSIDER
128AtaxiaSIDER
129Blood alkaline phosphatase increasedSIDER
130Blood and lymphatic system disordersSIDER
131Bone lesionSIDER
132Chemical and Drug Induced Liver Injury329728
6724195
CTD
133ConstipationSIDER
134DermatitisSIDER
135Diffuse Large B-Cell LymphomaSIDER
136DiscomfortSIDER
137Duodenal Ulcer

View details

CTD
138DuodenitisSIDER
139DyspepsiaSIDER
140ErythemaSIDER
141Feeling abnormalSIDER
142Feeling jitterySIDER
143GastroenteritisSIDER
144Gastrointestinal PainSIDER
145Gastrointestinal ulcerSIDER
146HyperkinesiaSIDER
147LeukopeniaSIDER
148Mood swingsSIDER
149Myoclonus3110644CTD
150Necrosis6724195CTD
151Neoplasm Invasiveness22532830CTD
152Neoplasm Metastasis22532830CTD
153Optic NeuritisSIDER
154PseudotumorSIDER
155RednessSIDER
156ScotomaSIDER
157Stevens-Johnson Syndrome25811541CTD
158Stomach Diseases3613839CTD
159TensionSIDER
160TremorSIDER
161Urologic Diseases2810938CTD
162UrticariaSIDER
163nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.